1h Free Analyst Time
The influenza diagnostics market is forecasted to grow by USD 517.5 million during 2023-2028, accelerating at a CAGR of 7.22% during the forecast period. The report on the influenza diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of influenza, growing demand for molecular diagnostics, and supportive government initiatives and funding.
The influenza diagnostics market is segmented as below:
By End-user
- Hospitals and diagnostic laboratories
- Academic and research centers
- Homecare
By Type
- Point-of-care testing
- Immunodiagnostics
- Molecular diagnostics
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the influenza diagnostics market covers the following areas:
- Influenza diagnostics market sizing
- Influenza diagnostics market forecast
- Influenza diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global influenza diagnostics market: Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Quidelortho Corp., Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising approvals for influenza diagnostic products."
According to the report, one of the major drivers for this market is the rising incidence of influenza.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- BICO Group AB
- Bio Rad Laboratories Inc.
- Biocartis NV
- bioMerieux SA
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Hologic Inc.
- Princeton BioMeditech Corp.
- QIAGEN NV
- Quidelortho Corp.
- Response Biomedical Corp.
- SA Scientific Ltd.
- Sd Biosensor Inc.
- Sekisui Chemical Co. Ltd.
- Siemens Healthineers AG
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
